|
Volumn 334, Issue 18, 1996, Pages 1178-1184
|
Drug therapy: Antiparasitic drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBENDAZOLE;
ANTIPARASITIC AGENT;
BITHIONOL;
COTRIMOXAZOLE;
FUMAGILLIN;
IVERMECTIN;
MEBENDAZOLE;
METRONIDAZOLE;
NICLOSAMIDE;
PAROMOMYCIN;
PRAZIQUANTEL;
PYRANTEL EMBONATE;
TIABENDAZOLE;
ANTHELMINTIC AGENT;
ANTIPROTOZOAL AGENT;
DRUG;
ASCARIASIS;
CESTODE;
COCCIDIOSIS;
CYSTICERCOSIS;
DRUG INDICATION;
ECHINOCOCCOSIS;
ENTEROBIASIS;
FASCIOLIASIS;
GIARDIASIS;
ONCHOCERCIASIS;
PARASITOSIS;
PRIORITY JOURNAL;
REVIEW;
SCHISTOSOMIASIS;
STRONGYLOIDIASIS;
TRICHURIASIS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DISEASES;
ECONOMIC FACTORS;
HELMINTHIASIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LITERATURE REVIEW;
PROTOZOAL INFECTION;
RESEARCH AND DEVELOPMENT;
TECHNOLOGY;
TREATMENT;
VIRAL DISEASES;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
DISEASES;
DRUGS;
ECONOMIC FACTORS;
HIV INFECTIONS;
LITERATURE REVIEW;
PARASITIC DISEASES;
RESEARCH AND DEVELOPMENT;
TECHNOLOGY;
TREATMENT;
VIRAL DISEASES;
ANTHELMINTICS;
ANTIPROTOZOAL AGENTS;
HELMINTHIASIS;
HUMANS;
PROTOZOAN INFECTIONS;
|
EID: 0030563173
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199605023341808 Document Type: Review |
Times cited : (164)
|
References (0)
|